Author:
Fumagalli Laura,Young Florence L.,Boeynaems Steven,Decker Mathias De,Mehta Arpan R.,Swijsen Ann,Fazal Raheem,Guo Wenting,Moisse Matthieu,Beckers Jimmy,Dedeene Lieselot,Selvaraj Bhuvaneish T.,Vandoorne Tijs,Madan Vanesa,van Blitterswijk Marka,Raitcheva Denitza,McCampbell Alexander,Poesen Koen,Gitler Aaron D.,Koch Phillip,Berghe Pieter Vanden,Thal Dietmar Rudolf,Verfaillie Catherine,Chandran Siddharthan,Van Den Bosch Ludo,Bullock Simon L.,Damme Philip Van
Abstract
ABSTRACTHexanucleotide repeat expansions in the C9orf72 gene are the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). How this mutation leads to these neurodegenerative diseases remains unclear. Here, we use human induced pluripotent stem cell-derived motor neurons to show that C9orf72 repeat expansions impair microtubule-based transport of mitochondria, a process critical for maintenance of neuronal function. Cargo transport defects are recapitulated by treating healthy neurons with the arginine-rich dipeptide repeat proteins (DPRs) that are produced by the hexanucleotide repeat expansions. Single-molecule imaging shows that these DPRs perturb motility of purified kinesin-1 and cytoplasmic dynein-1 motors along microtubules in vitro. Additional in vitro and in vivo data indicate that the DPRs impair transport by interacting with both microtubules and the motor complexes. We also show that kinesin-1 is enriched in DPR inclusions in patient brains and that increasing the level of this motor strongly suppresses the toxic effects of arginine-rich DPR expression in a Drosophila model. Collectively, our study implicates an inhibitory interaction of arginine-rich DPRs with the axonal transport machinery in C9orf72-associated ALS/FTD and thereby points to novel potential therapeutic strategies.
Publisher
Cold Spring Harbor Laboratory
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献